Searched for
RIVASTIGMINE TARTRATE
China halts sale of Sun Pharma drug used to treat dementiaChina's medicine regulator has halted the import, sale, and use of Sun Pharmaceutical Industries' dementia drug, rivastigmine hydrogen tart...- Aurobindo Pharma gets final USFDA nod for dementia drugDrug firm Aurobindo Pharma has received final approval from USFDA to manufacture and market Rivastigmine Tartrate Capsules USP.
- Dr Reddy's recalls Rivastigmine Tartrate capsules of 1.5 mg strength from USDr Reddy's Laboratories (DRL) has initiated voluntary recall of Rivastigmine Tartrate Capsules of 1.5 mg strength from the USA market.
- Alembic Pharmaceuticals soars on patent settlement case with NovartisShares of Alembic Pharma surged by over 4% after the co said it along with Breckenridge Pharma Inc, USA has settled a patent case with Nova...
- Indian generic companies may tread Ranbaxy pathRanbaxy's patent settlement with Pfizer may lead more Indian generic cos to go for out-of-court settlements with their innovator counterpar...
- DRL, Novartis smoke peace pipe on Alzheimer's drugDr Reddy’s Laboratories (DRL) has entered a settlement agreement with Novartis Pharma to suspend the launch of its generic capsule rivastig...
- Sun settles patent row with NovartisSun Pharmaceutical Industries has reached an out-of-court settlement with Novartis in the United States with regard to a patent dispute ove...
- Sun, Novartis settle Exelon drug disputeSun Pharmaceutical has reached an out-of-court settlement with Novartis in the US with regard to a patent dispute over the Swiss drug major...
- Stocks to watch on ThursdayShares of airline companies are likely to see some pressure as the government has asked airlines to come clean on the tax component.
- Sun Pharma gets US nod for Novartis' ExelonSun Pharma said it has won a 180-day marketing exclusivity for its version of Novartis' $200-million drug Exelon in the US.
- DRL gets tentative USFDA nod for Alzheimer's drugDr Reddy's Laboratories Ltd has received tentative approval from the USFDA for the drug 'Rivastigmine' in capsule form.
Load More- Alembic Pharmaceuticals soars on patent settlement case with Novartis
